IPO registrations (S-1, F-1) · Registrants
Sagent Pharmaceuticals, Inc.
- SEC CIK
- 1369786 · filings on EDGAR ↗
- Name on the registration
- Sagent Holding Co.
- Former names
- Sagent Holding Co. (2009–2011); NHS PHARMACEUTICALS (2006–2006)
- Registration
- Form S-1, first filed 2010-12-06, last 2011-04-15; 1 initial registration, 5 amendments
- Outcome
- Declared effective 2011-04-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1901 NORTH ROSELLE ROAD, SUITE 700, Schaumburg, IL 60195
- EDGAR entity type
- operating
- Insiders and CEO pay
- Sagent Pharmaceuticals, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2011-04-15)
- Shares offered
- 5,000,000
- Listing
- Nasdaq under the symbol SGNT
- Lead underwriters
- Morgan Stanley
- Syndicate
- BofA Securities; Jefferies; Needham & Company; RBC Capital Markets
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SAGENT PHARMACEUTICALS Fuzzy (name and state)
- Business registration: SAGENT PHARMACEUTICALS CORP Fuzzy (name and state)
- Business registration: Sagent Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: SAGENT PHARMACEUTICALS INC Fuzzy (name and state)
- Business registration: SAGENT PHARMACEUTICALS, INC. Fuzzy (name and state)
- Federal award recipient: SAGENT PHARMACEUTICALS, INC Fuzzy (name and state)
- SEC filer: Sagent Holding Co. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-12-06 | S-1 | S-1 (registration) | Sagent Holding Co. | 0001193125-10-273969 ↗ |
| 2011-02-02 | S-1/A | S-1/A (amendment) | Sagent Holding Co. | 0001193125-11-020629 ↗ |
| 2011-03-18 | S-1/A | S-1/A (amendment) | Sagent Holding Co. | 0001193125-11-070217 ↗ |
| 2011-04-06 | S-1/A | S-1/A (amendment) | Sagent Holding Co. | 0001193125-11-089495 ↗ |
| 2011-04-11 | S-1/A | S-1/A (amendment) | Sagent Holding Co. | 0001193125-11-092760 ↗ |
| 2011-04-15 | S-1/A | S-1/A (amendment) | Sagent Holding Co. | 0001193125-11-099723 ↗ |
| 2011-04-19 | S-1MEF | S-1MEF (added securities) | Sagent Holding Co. | 0001193125-11-102738 ↗ |
| 2011-04-19 | EFFECT | EFFECT (declared effective) | Sagent Holding Co. | 9999999995-11-001071 ↗ |
| 2013-02-05 | EFFECT | EFFECT (declared effective) | Sagent Pharmaceuticals, Inc. | 9999999995-13-000396 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-04-15 | S-1/A | registration statement | $14.00–$16.00 | $15.00 | 5,000,000 | $75,000,000 | Nasdaq SGNT | 5 | primary document; range, price sentence, shares headline, proceeds computed, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Behrens Mary Taylor | Director | 13 | 2011–2016 | ||
| China Harvest Fund II, LP | TenPercentOwner | 11 | 2011–2012 | ||
| China Renaissance Capital Investment II GP | TenPercentOwner | 11 | 2011–2012 | ||
| China Renaissance Capital Investment II, L.P. | TenPercentOwner | 11 | 2011–2012 | ||
| Drake Lorin | Officer | Corporate VP, Sales; Executive VP, Sales; VP, Sales and Marketing | 15 | 2011–2016 | |
| FLANAGAN ROBERT J | Director | 31 | 2011–2016 | ||
| Hebeda Dave | Officer | Vice President, Finance | 2 | 2011–2012 | |
| Key Gate Investments Ltd | TenPercentOwner | 11 | 2011–2012 | ||
| Krizman Anthony | Director | 13 | 2011–2016 | ||
| KUNG FRANK | Director | 14 | 2011–2015 | ||
| Logerfo Michael | Officer | Chief Legal Officer; President; President, CLO; President, CLO and Secretary | 26 | 2011–2016 | |
| Patterson Albert | Officer | EVP, Nat. Accts and Corp. Dev.; Executive VP, Operations; Senior VP, Operations | 18 | 2011–2016 | |
| Pauli Ronald | Officer | Chief Financial Officer | 2 | 2011–2012 | |
| Sperans James | Director | 2 | 2011–2012 | ||
| Vivo Ventures Fund VI, L.P. | TenPercentOwner | 5 | 2011–2016 | ||
| Vivo Ventures Fund V, L.P. | TenPercentOwner | 5 | 2011–2016 | ||
| Vivo Ventures V Affiliates Fund, L.P. | TenPercentOwner | 5 | 2011–2016 | ||
| VIVO VENTURES VI AFFIILATES FUND, L.P. | TenPercentOwner | 5 | 2011–2016 | ||
| Vivo Ventures VI, LLC | TenPercentOwner | 5 | 2011–2016 | ||
| Vivo Ventures V, LLC | TenPercentOwner | 5 | 2011–2016 | ||
| YORDON JEFFREY | Director; Director,Officer | Chief Executive Officer | 12 | 2011–2015 | |
| Yu Chen-Ming | Director; Officer | Interim COO | 5 | 2011–2012 | |
| MORGAN STANLEY AIP GP LP | TenPercentOwner | 13 | 2011–2015 | ||
| MORGAN STANLEY INVESTMENT MANAGEMENT INC | TenPercentOwner | 13 | 2011–2015 | ||
| Singer Jonathon M | Officer | Chief Financial Officer; EVP and CFO | 16 | 2011–2016 | |
| Greve Jeffrey W. | Officer | Vice President, Controller | 6 | 2012–2016 | |
| HUSSEY JAMES M | Officer | President | 5 | 2013–2015 | |
| FEKETE MICHAEL | Director | 13 | 2013–2016 | ||
| Yanai Shlomo | Director | 5 | 2015–2016 | ||
| SHEA THOMAS JOSEPH | Officer | VP, Global Alliance Management | 3 | 2015–2016 | |
| OBERMAN ALLAN | Director,Officer | Chief Executive Officer | 5 | 2015–2016 | |
| Harmon J Frank | Officer | EVP, Global Operations | 3 | 2016 | |
| BRYNJELSEN SEAN | Officer | EVP, Business Development; EVP, Business Development | 3 | 2016 | |
| WARD MICHAEL V. | Officer | Chief Legal Off. and Secretary | 2 | 2016 | |
| BULLOCK DONALD R | Officer | Executive V.P. Sales | 3 | 2016 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | SAGENT PHARMACEUTICALS | IL | State business registries | name and state |
| Business registration | SAGENT PHARMACEUTICALS CORP | IL | State business registries | name and state |
| Business registration | Sagent Pharmaceuticals Inc. | IL | State business registries | name and state |
| Business registration | SAGENT PHARMACEUTICALS INC | IL | State business registries | name and state |
| Business registration | SAGENT PHARMACEUTICALS, INC. | IL | State business registries | name and state |
| Federal award recipient | SAGENT PHARMACEUTICALS, INC | IL | Federal spending (USAspending) | name and state |
| Paying company | Sagent Pharmaceuticals | IL | Open Payments (drug and device company payments) | name and state |
| SEC filer | Sagent Pharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Sagent Pharmaceuticals, Inc. | IL | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, IL first:
- APP Pharmaceuticals, Inc. IL
- XERIS PHARMACEUTICALS INC IL
- Wellness Center USA, Inc. IL
- Durata Therapeutics, Inc. IL
- AbbVie Inc. IL
- PharMEDium Healthcare Holdings, Inc. IL
- Baxalta Inc IL
- Accelerated Pharma, Inc. IL
- Monopar Therapeutics IL
- Aptinyx Inc. IL
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health